Ticker: MXCT

MaxCyte is a leader in cell transfection, bringing to market its patented flow electroporation technology. MaxCyte is focused in applying its significant capabilities in the discovery, development, and manufacturing of virtually all classes of innovative therapeutics targeting a broad range of chronic and acute diseases.

Latest Reports

Gearing up the growth

Published: 26th September 2016

Right here, right now: catching the CAR-T wave

Published: 12th July 2016